Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2

Eun‐Seo Lee(Tohoku University), Yasufumi Sato(Tohoku University)
The Tohoku Journal of Experimental Medicine
January 1, 2023
10.1620/tjem.2023.j076
Cited by 3

Related Papers

Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis
|Journal of Clinical Investigation|2004|287
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis
|Journal of Clinical Investigation|2004|263
Vasohibin‐2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor‐β signaling
|Cancer Science|2017|34
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody
|Cancer Medicine|2021|13